Observational Enrolling by invitation
NCT04757922 on ClinicalTrials.gov
Stop Ovarian Cancer Young; Effect of the Opportunistic Salpingectomy on Age of Menopause
- Sponsor: Radboud University Nijmegen Medical Centre
- Collaborators: Catharina Ziekenhuis Eindhoven
- Enrollment: 1200 (Estimated)
- Study start: 2021-03-01 (Actual)
- Primary completion: 2035-01-01 (Estimated)
- Study completion: 2036-01-01 (Estimated)
- Allocation: N/a
- InterventionModel: N/a
- Masking: None
- PrimaryPurpose: Other
Brief Summary
The aim of this study is to evaluate the long-term safety of on the onset of menopause.
Conditions
- Salpingectomy
- Tubal Ligation
- Menopause
Intervention / Treatment
- Procedure: Opportunistic salpingectomy / bilateral salpingectomy
Primary Outcome Measures
-
Menopausal age
(At end of follow-up (follow up ends at age of menopause with a maximum follow-up time of 15 years))
The age of reaching natural menopause (e.g. last menstruation \> 1 year ago )
Countries
Netherlands
Locations and Investigators
- Catharina Ziekenhuis, Eindhoven, Netherlands
Study Officials
- Jurgen MJ Piek, MD, PhD (Principal Investigator) — Catharina Ziekenhuis
- Joanne A de Hullu, MD, PhD (Principal Investigator) — University Medical Center Nijmegen